Eudaimonia Partners’s PetMed Express PETS Stock Holding History

Eudaimonia Partners’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-800	Closed	-$28K	–	1073
2021 Q1	$28K	Sell	800 -120	-13%	-$4.17K	0.01%	842
2020 Q4	$29K	Sell	920 -46	-5%	-$1.42K	0.01%	767
2020 Q3	$31K	Hold	966	–	–	0.01%	681
2020 Q2	$34K	Buy	966 +166	+21%	+$5.76K	0.01%	589
2020 Q1	$23K	Buy	+800	New	+$21K	0.01%	635

Other funds holding PETS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.2B AUM 41.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Eudaimonia Partners's PETS Position: Q2 2021 in Review

Eudaimonia Partners sold out of PetMed Express (PETS) in Q2 2021, closing a stake of 800 shares — an estimated $28K sold.

Eudaimonia Partners first reported a position in PETS in Q1 2020 and held it in 5 quarters. The position peaked at $34K in Q2 2020. 199 funds tracked by Wall St. Rank hold PETS as of Q2 2021.

Eudaimonia Partners reported no remaining PetMed Express position as of Q2 2021 after selling out during the quarter.
Eudaimonia Partners sold 800 PetMed Express shares in Q2 2021, an estimated $28K.
Eudaimonia Partners first reported a position in PetMed Express in Q1 2020 and held it in 5 quarters.
Eudaimonia Partners's PetMed Express position peaked at $34K in Q2 2020.
199 funds tracked by Wall St. Rank held PetMed Express as of Q2 2021.

Based on Eudaimonia Partners's 13F filing for Q2 2021, filed 13 Aug 2021.